JWCA
IDNA icon

J.W. Cole Advisors’s iShares Genomics Immunology and Healthcare ETF IDNA Stock Holding History

J.W. Cole Advisors’s Portfolio IDNA Stock Details IDNA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q4 		– Sell
-6,800
Closed -$265K – 747
2020
Q3 		$265K Buy
+6,800
New +$261K 0.02% 583

Other funds holding IDNA

Thrivent Financial for Lutherans
Thrivent Financial for Lutherans Minneapolis, Minnesota $52.5B AUM 27.12% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
RCS
Retirement Capital Strategies San Jose, California $265M AUM 11.86% 1-Year Est. Return
LPL Financial
LPL Financial San Diego, California $377B AUM 19.32% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return
WAP
Wealthcare Advisory Partners West Chester, Pennsylvania $5.27B AUM 22.23% 1-Year Est. Return
JMPWA
JP Morgan Private Wealth Advisors San Francisco, California $35B AUM 24.26% 1-Year Est. Return
SWM
Strategic Wealth Management Kirkland, Washington $202M AUM 9.35% 1-Year Est. Return
Stifel Financial
Stifel Financial St. Louis, Missouri $109B AUM 21.36% 1-Year Est. Return

J.W. Cole Advisors's IDNA Position: Q4 2020 in Review

J.W. Cole Advisors sold out of iShares Genomics Immunology and Healthcare ETF (IDNA) in Q4 2020, closing a stake of 6,800 shares — an estimated $265K sold.

J.W. Cole Advisors first reported a position in IDNA in Q3 2020 and held it in 1 quarter. The position peaked at $265K in Q3 2020. 63 funds tracked by Wall St. Rank hold IDNA as of Q4 2020.

  • J.W. Cole Advisors reported no remaining iShares Genomics Immunology and Healthcare ETF position as of Q4 2020 after selling out during the quarter.
  • J.W. Cole Advisors sold 6,800 iShares Genomics Immunology and Healthcare ETF shares in Q4 2020, an estimated $265K.
  • J.W. Cole Advisors first reported a position in iShares Genomics Immunology and Healthcare ETF in Q3 2020 and held it in 1 quarter.
  • J.W. Cole Advisors's iShares Genomics Immunology and Healthcare ETF position peaked at $265K in Q3 2020.
  • 63 funds tracked by Wall St. Rank held iShares Genomics Immunology and Healthcare ETF as of Q4 2020.

Based on J.W. Cole Advisors's 13F filing for Q4 2020, filed 12 Feb 2021.